BioXcel Therapeutics (BTAI) PT Raised to $4 at Mizuho, 'Next Financing Remains Our Focus'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. ARX

Go back to BioXcel Therapeutics (BTAI) PT Raised to $4 at Mizuho, 'Next Financing Remains Our Focus'
(NASDAQ: BTAI) Delayed: 1.13 +0.07 (6.60%)
Previous Close $1.06    52 Week High $ 
Open $1.10    52 Week Low $ 
Day High $1.16    P/E N/A 
Day Low $1.05    EPS $ 
Volume 1,085,284